Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of KRP-104 on glycemic
control in patients with type 2 diabetes inadequately controlled on metformin alone.